The Value of Three Immune Complex Assays in the Management of Systemic Lupus Erythematosus: an Assessment of Immune Complex Levels, Size and Immunochemical Properties in Relation to Disease Activity and Manifestations

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1980 May 1

PMID 7438538

Citations 8

Authors

S A Cairns

A London

N P Mallick

Affiliations

Soon will be listed here.

Abstract

Sixteen patients with systemic lupus erythematosus, fourteen with renal involvement have been studied over a 30-month period. Circulating immune complex levels have been assayed by three techniques. The results of tests on 141 sequential sera suggest that the three assays detected overlapping populations of the range of complexes present. Immune complex levels are shown to be good markers of disease activity and certain immunochemical properties of the complexes emerged as better markers than others. Immune complex size is a more important determinant of disease manifestation than are overall immune complex levels. High doses of intravenous methyl prednisolone, which did not reduce overall complex levels, reduced levels of those complexes (molecular weight 600,000-900,000 Daltons) associated with renal involvement.

Citing Articles

Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis.

Richoz N, Tuong Z, Loudon K, Patino-Martinez E, Ferdinand J, Portet A JCI Insight. 2022; 7(21).

PMID: 36345939 PMC: 9675473. DOI: 10.1172/jci.insight.159751.

Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.

Siegert C, Daha M, Tseng C, Coremans I, van Es L, Breedveld F Ann Rheum Dis. 1993; 52(12):851-6.

PMID: 8311534 PMC: 1005214. DOI: 10.1136/ard.52.12.851.

A simple quantitative assay of circulating immune complexes by laser nephelometry, using a rabbit igg antibody against human aggregated igg.

Arai K, Shimizu A Clin Exp Immunol. 1981; 46(3):541-6.

PMID: 6802542 PMC: 1536299.

Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE).

Hurst N, Nuki G, Wallington T Clin Exp Immunol. 1984; 55(2):303-12.

PMID: 6697566 PMC: 1535827.

Neutrophil activation by immune complexes and the role of rheumatoid factor.

Gale R, Bertouch J, Gordon T, Bradley J, Roberts-Thomson P Ann Rheum Dis. 1984; 43(1):34-9.

PMID: 6696514 PMC: 1001214. DOI: 10.1136/ard.43.1.34.

References

Mancini G, Carbonara A, Heremans J . Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965; 2(3):235-54. DOI: 10.1016/0019-2791(65)90004-2. View

Pincus T, Schur P, Rose J, Decker J, Talal N . Measurement of serum DNA-binding activity in systemic lupus erythematosus. N Engl J Med. 1969; 281(13):701-5. DOI: 10.1056/NEJM196909252811304. View

Yonemasu K, Stroud R . Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies. J Immunol. 1971; 106(2):304-13. View

Cochrane C, Koffler D . Immune complex disease in experimental animals and man. Adv Immunol. 1973; 16(0):185-264. DOI: 10.1016/s0065-2776(08)60298-9. View

CRUCHAUD A, Chenais F, Fournie G, HUMAIR L, Lambert P, Mulli J . Immune complex deposits in systemic lupus erythematosus kidney without histological or functional alterations. Eur J Clin Invest. 1975; 5(3):297-309. DOI: 10.1111/j.1365-2362.1975.tb00458.x. View

Cathcart E, Idelson B, Scheinberg M, Couser W . Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet. 1976; 1(7952):163-6. DOI: 10.1016/s0140-6736(76)91272-1. View

Hay F, Nineham L, Roitt I . Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Clin Exp Immunol. 1976; 24(3):396-400. PMC: 1538525. View

Cameron J, Lessof M, Ogg C, Williams B, Williams D . Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol. 1976; 25(3):418-27. PMC: 1541413. View

Levinsky R, Cameron J, Soothill J . Serum immune complexes and disease activity in lupus nephritis. Lancet. 1977; 1(8011):564-7. DOI: 10.1016/s0140-6736(77)91998-5. View

10.

Izui S, Lambert P, Fournie G, Turler H, MIESCHER P . Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes. J Exp Med. 1977; 145(5):1115-30. PMC: 2180666. DOI: 10.1084/jem.145.5.1115. View

11.

Davis P, PERCY J, Russell A . Correlation between levels of DNA antibodies and clinical disease activity in SLE. Ann Rheum Dis. 1977; 36(2):157-9. PMC: 1006651. DOI: 10.1136/ard.36.2.157. View

12.

Levinsky R, Soothill J . A test for antigen--antibody complexes in human sera using IgM of rabbit antisera to human immunoglobulins. Clin Exp Immunol. 1977; 29(3):428-35. PMC: 1541081. View

13.

HOLBOROW E . The serology of connective tissue disorders. Br J Hosp Med. 1978; 19(3):250, 252, 257-8. View

14.

Pussell B, Lockwood C, Scott D, Pinching A, PETERS D . Value of immune-complex assays in diagnosis and management. Lancet. 1978; 2(8085):359-64. DOI: 10.1016/s0140-6736(78)92954-9. View

15.

Dosa S, Cairns S, Lawler W, Mallick N, Slotki I . The treatment of lupus nephritis by methyl prednisolone pulse therapy. Postgrad Med J. 1978; 54(635):628-32. PMC: 2425230. DOI: 10.1136/pgmj.54.635.628. View

16.

Lockwood C, Worlledge S, Nicholas A, Cotton C, PETERS D . Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med. 1979; 300(10):524-30. DOI: 10.1056/NEJM197903083001003. View